Fig. 7.
Treatment of MER myeloma cells with anti-CD9 mAb ALB6 abrogates the effects of PWM.
MER cells were incubated in the presence of ALB6 or anti–HLA-DR mAb (10 μg/mL) for 24 hours. PWM (1%) was then added, and the cells were allowed to incubate for an additional 2 hours prior to labeling with51Cr. Cells were then used as targets in 4-hour51Cr release assays after extensive washing. This experiment represents 1 of 3 similar experiments.
